Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients.

@article{Nrnberg2009ReducedS2,
  title={Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients.},
  author={Bernd N{\"u}rnberg and Stefan Gr{\"a}ber and Babette G{\"a}rtner and Juergen Geisel and Claudia Pf{\"o}hler and Dirk Schadendorf and Wolfgang Tilgen and Joerg Reichrath},
  journal={Anticancer research},
  year={2009},
  volume={29 9},
  pages={
          3669-74
        }
}
BACKGROUND Reduced serum 25-hydroxyvitamin D3 (25(OH)D) levels are associated with an increased incidence and an unfavorable outcome of various types of cancer. However, the influence of serum 25(OH)D on the incidence and outcome of patients with malignant melanoma is unknown. PATIENTS AND METHODS The association between serum 25(OH)D levels and clinical and histopathological data among 205 patients with malignant melanoma was examined. Additionally, 141 healthy controls were investigated… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

Similar Papers

Loading similar papers…